Know Cancer

or
forgot password
  • cancer clinical trials in bethesda, MD

  • White Blood Cells With Anti-EGFR-III for Malignant Gliomas
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Malignant Glioma, Glioblastoma, Brain Cancer
    Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Myelodysplastic Syndrome (MDS)
    Effects of Hormone Stimulation on Brain Scans for Cushing's Disease
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Pituitary Neoplasm
    Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Hodgkin Disease, Hodgkin Lymphoma
    AZD7451 for Recurrent Gliomas
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Glioblastoma Multiforme
    A Pilot Study of the Administration of Young Tumor Infiltrating Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotrheraphy Regimen in Metastatic Melanoma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Metastatic Melanoma, Skin Cancer
    The Treatment of Stage I and II Breast Cancer With Mastectomy and Axillary Dissection vs. Excisional Biopsy, Axillary Dissection, and Radiotherapy
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Breast Cancer
    Pazopanib and ARQ 197 for Advanced Solid Tumors
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Sarcoma, Stomach Neoplasms, Neoplasms
    Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
    Naval Medical Research Center
    Bethesda, Maryland 20889
    Bone Metastases
    A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Multiple Myeloma
    Efficacy and Safety Study of NeuVax(TM)(Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
    Center of Cancer and Blood Disorders (VEEDA network)
    Bethesda, Maryland 20817
    HER2 Negative Breast Cancer
    Imaging Study for FdCyd and THU Cancer Treatment
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Head and Neck Neoplasms, Lung Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    Center for Cancer and Blood Disorders, PC
    Bethesda, Maryland 20817
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Mestatic Melanoma, Skin Cancer
    Lonafarnib for Chronic Hepatitis D
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Hepatitis D
    Pomalidomide for Kaposi Sarcoma in People With or Without HIV
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Sarcoma, Kaposi
    Family Genetics Health Education and Healthy Behaviors
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Diabetes, Cancer, Heart Disease
    PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Leukemia, Leukemia, Lymphocytyc, CLL (Chronic Lymphocytic Leukemia), SLL (Small Lymphocytic Lymphoma)
    Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
    Mark O Hatfield-Warren Grant Magnuson Clinical Center
    Bethesda, Maryland 20892
    Childhood Hepatocellular Carcinoma, Papillary Thyroid Cancer, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Thyroid Cancer, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas
    National Cancer Institute Pediatric Oncology Branch
    Bethesda, Maryland 20892
    Childhood Mixed Glioma, Untreated Childhood Anaplastic Astrocytoma, Untreated Childhood Brain Stem Glioma, Untreated Childhood Giant Cell Glioblastoma, Untreated Childhood Glioblastoma, Untreated Childhood Gliosarcoma
    Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
    Sandoz Investigational Site
    Bethesda, Maryland 20817
    Chemotherapy-induced Neutropenia, Breast Cancer
    Improving Blood Stem Cell Collection and Transplant Procedures
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, CML (Chronic Myelogenous Leukemia, CLL (Chronic Lymphocytic Leukemia), Acute Myeloid Leukemia (AML)
    Testing a Spanish Version of a Patient Toxicity Questionnaire
    National Cancer Institute (NCI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Cancer
    Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
    National Cancer Institute
    Bethesda, Maryland 20892-1922
    Rhabdomyosarcoma and Other Soft Tissue Sarcomas, Ewing's Sarcoma Family of Tumors, Osteosarcoma, Neuroblastoma, Brain Tumors
    Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Locally Advanced HER2-Negative Breast Cancer
    FdCyd and THU for Advanced Solid Tumors
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Neoplasms
    Collection of Transplant Stem Cells for Plasma Cell Myeloma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Plasma Cell Myeloma
    Studying Blood Toxicity in Workers Exposed to Formaldehyde
    National Cancer Institute (NCI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Formaldehyde, Hematotoxicity, Leukemia
    Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
    Mark O Hatfield-Warren Grant Magnuson Clinical Center
    Bethesda, Maryland 20892
    Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Visual Pathway Glioma
    AMG 386 and Abiraterone for Advanced Prostate Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Prostatic Neoplams, Prostate Cancer, Neoplasm, Prostate, Neoplasm,Prostatic
    Transplants With Unlicensed Preserved Cord Blood
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Myelodysplastic Syndrome (MDS), Hematologic Neoplasms, Hematologic Diseases, Severe Aplastic Anemia
    Clobetasol for Oral Graft-Versus-Host Disease
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Oral Chronic Graft vs Host Disease
    Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)
    Site Reference ID/Investigator# 74033
    Bethesda, Maryland 20817
    Chronic Lymphocytic Leukemia
    Phase 3 Study With Carfilzomib and Dexamethasone Versus Velcade and Dexamethasone for Relapsed Multiple Myeloma Patients
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Multiple Myeloma
    Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Multiple Myeloma
    Continuous Infusion of rhIL-15 for Adults With Advanced Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Carcinoma, Lymphoma
    Phase Ib Trial of Folate Binding Protein Vaccine in Ovarian Cancer
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Ovarian Cancer, Endometrial Cancer
    PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Solid Tumors, Lymphoma
    Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Chronic Hepatitis B e Antigen Positive, Chronic Hepatitis B e Antigen Negative
    Treating Cancer With Anti-mesothelin Modified Lymphocytes
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Metastatic Cancer, Pancreatic Cancer, Mesothelioma
    Vemurafenib and White Blood Cell Therapy for Advanced Melanoma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Metastatic Cancer, Melanoma
    A Phase II Study of Lymphodepletion Followed by Autologous Tumor-Infiltrating Lymphocytes and High-Dose Adesleukin for Human Papillomavirus-Associated Cancers
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Cervical Cancer, Oropharyngeal Cancer, Vaginal Cancer, Anal Cancer, Penile Cancer
    Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    ALL, B Cell Lymphoma, Leukemia, Large Cell Lymphoma, Non-Hodgkin Lymphoma
    A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bethesda, Maryland 20817
    Neoplasms, Hematologic
    Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Ewing Sarcoma, Sarcoma
    Sunitinib for Advanced Thymus Cancer Following Earlier Treatment
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Thymoma, Thymus Neoplasms
    Mithramycin for Lung, Esophagus, and Other Chest Cancers
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Lung Cancer, Esophageal Cancer, Mesothelioma, Gastrointestinal Neoplasms, Breast Cancer
    KW 0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
    National Cancer Institute
    Bethesda, Maryland 20892-1922
    Adult T-cell Leukemia-Lymphoma
    Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Myeldysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia, Bone Marrow Diseases, Neutropenia, Acute Myeloid Leukemia (AML)
    Effects of Treatments on Atopic Dermatitis
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Dermatitis, Atopic, Human Volunteers, Eczema, Atopic Dermatitis
    Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic Pain
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Neurofibromatosis
    Developing the Family Map: Looking at Communal Coping
    National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Diabetes, Cancer, Cardiovascular Disease
    Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
    National Institutes of Health
    Bethesda, Maryland 20892
    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Hepatic Complications, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Male Breast Cancer, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Nodal Marginal Zone B-cell Lymphoma, Noncutaneous Extranodal Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Basal Cell Carcinoma of the Lip, Recurrent Bladder Cancer, Recurrent Breast Cancer, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Lymphoepithelioma of the Oropharynx, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Melanoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Pancreatic Cancer, Recurrent Salivary Gland Cancer, Recurrent Small Lymphocytic Lymphoma, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage III Adenoid Cystic Carcinoma of the Oral Cavity, Stage III Basal Cell Carcinoma of the Lip, Stage III Bladder Cancer, Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Lymphoepithelioma of the Oropharynx, Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage III Mucoepidermoid Carcinoma of the Oral Cavity, Stage III Pancreatic Cancer, Stage III Salivary Gland Cancer, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage III Verrucous Carcinoma of the Larynx, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IIIA Breast Cancer, Stage IIIA Melanoma, Stage IIIB Breast Cancer, Stage IIIB Melanoma, Stage IIIC Breast Cancer, Stage IIIC Melanoma, Stage IV Bladder Cancer, Stage IV Breast Cancer, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Melanoma, Stage IV Pancreatic Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity, Stage IVA Basal Cell Carcinoma of the Lip, Stage IVA Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVA Lymphoepithelioma of the Oropharynx, Stage IVA Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVA Mucoepidermoid Carcinoma of the Oral Cavity, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity, Stage IVB Basal Cell Carcinoma of the Lip, Stage IVB Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVB Lymphoepithelioma of the Oropharynx, Stage IVB Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVB Mucoepidermoid Carcinoma of the Oral Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity, Stage IVC Basal Cell Carcinoma of the Lip, Stage IVC Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVC Lymphoepithelioma of the Oropharynx, Stage IVC Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVC Mucoepidermoid Carcinoma of the Oral Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Oropharynx, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, T-cell Large Granular Lymphocyte Leukemia, Testicular Lymphoma, Tongue Cancer, Waldenström Macroglobulinemia
    Validating Pain Scales in Children and Young Adults
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Solid Tumor, Leukemia, Neurofibromatosis
    Uncertain Genetic Test Results for Lynch Syndrome
    National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    HNPCC
    Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
    TG Therapeutics Investigational Trial Site
    Bethesda, Maryland 20817
    Non-Hodgkins Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Primary Central Nervous System Lymphoma
    The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Pain, Peripheral Neuropathy, Neuropathic Pain
    Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Multiple Myeloma, Leukemia, Plasma Cell
    Collecting Solid Tumor Tissue to Identify New Treatments
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Gastrointestinal Cancer, Liver Cancer, Pancreatic Cancer, Melanoma
    Natural History Study of Children and Young Adults With Medullary Thyroid Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Medullary Thyroid Carcer
    Testing the FLASHE Survey
    National Cancer Institute (NCI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Cognitive Testing, Interview, Survey
    Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
    National Cancer Institute
    Bethesda, Maryland 20892-1922
    Malignant Peripheral Nerve Sheath Tumors, MPNST, Sarcoma
    A Study of LY2228820 for Recurrent Ovarian Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bethesda, Maryland 20817
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    Fluorodeoxyglucose Imaging Studies to Detect Lymphoma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Autoimmune Lymphoproliferative Syndrome, Lymphoma
    ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Colorectal Neoplasms, Colorectal Carcinoma, Colorectal Tumors
    Lenalidomide Maintenance Therapy for Multiple Myeloma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Multiple Myeloma
    CRS-207 Cancer Vaccine in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
    National Cancer Institute
    Bethesda, Maryland 20892-1922
    Malignant Pleural Mesothelioma
    Tissue Collection for Studies of Lymph Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Lymphomatoid Granulomatosis, Leukemia-Lymphoma, Adult T-Cell
    Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Epithelial Ovarian Cancer, Peritoneal Neoplasms, Fallopian Tube Neoplasms
    The Effect of Postoperative Interferon- Alpha Treatment in Low miR-26 Expression Patients With HCC
    National Cancer Institute, NIH, US
    Bethesda, Maryland 20892
    Hepatocellular Carcinoma
    Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Prostatic Neoplasms
    A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate
    Center for Cancer & Blood Disorders
    Bethesda, Maryland 20817
    Prostate Cancer